Humanin-G Protected Mouse Lungs After Hemorrhagic Shock Through Both AMPK-Dependent and Independent Pathways | Research

The takeaway

The mitochondrial peptide analog humanin-G reduced lung damage after hemorrhagic shock in mice, with some protective effects depending on the AMPKα1 energy-sensing pathway and others working independently of it.

Dual protective mechanisms
Humanin-G improved lung structure regardless of AMPKα1 status, but reduced immune cell infiltration only when AMPKα1 was present — showing the peptide works through multiple independent pathways.

What the researchers found

Humanin-G produced several protective effects after hemorrhagic shock:

• Ameliorated histological lung damage in all groups — male and female, regardless of AMPKα1 status

• Reduced lung neutrophil infiltration in male and female AMPKα1 wild-type mice only — not in knockouts, indicating this effect requires AMPKα1

• Improved mean arterial blood pressure in male AMPKα1 knockout mice

• Activated AMPKα in lung tissue (cytosolic and nuclear) in wild-type mice

• Did not modify STAT3 activation

Key sex differences emerged: male wild-type mice had more pronounced neutrophil infiltration than females, and male AMPKα1 knockout mice experienced significant blood pressure declines after resuscitation compared to male wild-types. Hemorrhagic shock downregulated AMPKα1/α2 catalytic subunits in wild-type mice.

Why it matters

Acute lung injury after hemorrhagic shock is a leading cause of death in trauma patients, and there are no specific pharmacological treatments for it. Humanin-G's ability to protect lung tissue through multiple mechanisms — some dependent on AMPK and others not — suggests it could provide broad protection even in patients whose AMPK activity has declined with age. The sex-dependent findings are also clinically important, as men and women may need different treatment approaches.

How the study worked

Male and female AMPKα1 wild-type and knockout mice (8-13 months old, mimicking adult human patients) underwent hemorrhagic shock by controlled blood withdrawal, followed by resuscitation with their own shed blood plus lactated Ringer's solution. Mice were treated with PEGylated humanin-G or vehicle (control). Three hours after resuscitation, lungs were assessed histologically for injury scores, neutrophil infiltration, and molecular markers including AMPKα1/α2 subunits, STAT3, and other signaling proteins via western blot and other analyses.

What this study cannot tell us

This is an animal study with a 3-hour post-resuscitation endpoint, which may not capture longer-term lung recovery or late-onset injury. The abstract does not specify the number of mice per group. The hemorrhagic shock model, while clinically relevant, involves controlled blood withdrawal that may not fully replicate the uncontrolled hemorrhage seen in trauma patients. PEGylated humanin-G was used (for longer half-life), and results may differ from native humanin. The 8-13 month mouse age range introduces variability.

How to read the evidence

This is an original preclinical animal study using genetically modified mice with both wild-type and knockout controls, plus sex as a biological variable. The design is rigorous for animal research, but findings remain preclinical and require human validation.

When this study was published

Published in 2024, this is very recent preclinical research. Humanin analogs have not yet entered clinical trials for acute lung injury or hemorrhagic shock, so clinical application is still distant.

The bigger picture

Humanin is a naturally occurring mitochondrial-derived peptide linked to longevity and cellular protection. This study extends humanin's known cytoprotective effects to acute trauma — a very different context from its usual association with aging and neurodegeneration. The finding that humanin-G works through both AMPK-dependent and AMPK-independent mechanisms is significant because AMPK activity declines with age, meaning a treatment that works even without full AMPK function could benefit the older patients who are most vulnerable to hemorrhagic shock complications.

Questions still open

Would humanin-G be effective if administered after resuscitation rather than during, as would be more practical in a trauma setting?
Do the sex differences in lung injury response translate to human patients, and should hemorrhagic shock treatment be sex-specific?
Could humanin-G protect other organs (kidneys, heart) from hemorrhagic shock damage through similar mechanisms?

Common questions

What is humanin and why might it protect the lungs?

Humanin is a small peptide naturally produced by mitochondria — the energy factories inside your cells. It protects cells against oxidative stress and damage, and is associated with longevity. When hemorrhagic shock triggers severe inflammation in the lungs, humanin-G (a modified analog) appears to reduce this damage by activating cellular energy-sensing pathways and through additional protective mechanisms that scientists are still working to fully understand.

Why did male and female mice respond differently to hemorrhagic shock?

The study found that male mice had more severe lung inflammation (neutrophil infiltration) than females after hemorrhagic shock, and male mice lacking the AMPKα1 enzyme had worse blood pressure recovery. These sex differences mirror what's seen in human trauma patients — men generally have worse outcomes after hemorrhagic shock — and are thought to involve differences in hormones, immune function, and metabolic pathways between the sexes.

Read the original research

Humanin-G Ameliorates Hemorrhage-Induced Acute Lung Injury in Mice Through AMPKα1-Dependent and -Independent Mechanisms.

Biomedicines, 12(11)

View on PubMed ↗Publisher’s paper ↗

Citation

Amman, Allison M; Wolfe, Vivian; Piraino, Giovanna; Ziady, Assem; Zingarelli, Basilia. (2024). Humanin-G Ameliorates Hemorrhage-Induced Acute Lung Injury in Mice Through AMPKα1-Dependent and -Independent Mechanisms.. Biomedicines, 12(11). https://doi.org/10.3390/biomedicines12112615